Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Peregrine Pharmaceuticals Inc PPHM.P

Healthcare Biotechnology


NDAQ:PPHM.P - Post by User

Peregrine Pharmaceuticals Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by peterfridayon Mar 25, 2016 2:49am
192 Views
Post# 24700247

Oncology pharma up 3%, new target price upgraded beyond sky

Oncology pharma up 3%, new target price upgraded beyond sky
Peregrine pharma with steady little revenus, no much debts, many innovative products on trials could become a great performers soon. Cancer is still no1 world treat,before any vampires...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities